There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
See the full list of benefits that ESMO members enjoy including access to OncologyPRO, subscription to Annals of Oncology and reduced meeting registration fees
A unique networking resource for ESMO members wishing to contact one another.
Attending ELCC 2015 in Geneva or DSKO in Nyborg, Denmark? If your are, please drop by our booth to learn about the benefits of ESMO membership!
We have a network of National and Regional Representatives who act as ambassadors of ESMO’s mission in their respective country or region
All the important ESMO dates and deadlines in a single place - don't miss out, update your diaries now!
The member panel gives feedback on ESMO products and services through the completion of regular online surveys. Would you like to contribute?
ESO-ESMO Advanced Breast Cancer • Primary Breast Cancer • BRCA in Breast Cancer
Cancers of Unknown Primary Site
High-Grade Malignant Glioma
Adrenal cancer • Thyroid cancer
Anal Cancer • Metastatic Colorectal Cancer • Oesophageal Cancer • Gastric Cancer • Early Colon Cancer • Familial Risk Colorectal Cancer • Rectal Cancer • Pancreatic Adenocarcinoma • Hepatocellular Carcinoma • Biliary Cancer
Bladder Cancer • Renal Cell Carcinoma • Prostate Cancer • Penile Carcinoma • Testicular Seminoma and Non-Seminoma
Endometrial Cancer • Gestational Trophoblastic-Disease • Newly-Diagnosed and Relapsed Epithelial Ovarian Carcinoma • Non-Epithelial Ovarian Cancer
Mantle Cell Lymphoma • Follicular Lymphoma • Hodgkin's Lymphoma • Primary Cutaneous Lymphoma • Multiple Myeloma • AML in Adult Patients • Waldenstrom's Macroglobulinaemia • Gastric Marginal Zone Lymphoma of MALT Type • CML • Diffuse Large B Cell Lymphoma • CLL
Nasopharyngeal Cancer • Squamous-Cell Carcinoma of the Head and Neck
Metastatic Non-Small-Cell Lung Cancer • Early-Stage and Locally Advanced (non metastatic) Non-Small-Cell Lung Cancer • Small-Cell Lung Cancer • Malignant Pleural Mesothelioma
Neuroendocrine Bronchial and Thymic Tumours • Neuroendocrine Gastroenteropancreatic Tumours
Soft Tissue and Visceral Sarcomas • Bone Sarcomas • Gastrointestinal Stromal Tumours
Refractory Symptoms • Advanced Care Planning • Bone Health • Cancer, Pregnancy and Fertility • Chemotherapy Extravasation • Cardiovascular Toxicity • Cancer Pain • Venous Thromboembolism • Mucositis • Erythropoiesis Stimulating Agents in the Treatment of Anaemia • Prevention of Chemotherapy and Radiotherapy Induced Nausea and Vomiting • Febrile Neutropenia • Haematopoietic Growth Factors
Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients
European Lung Cancer Conference 2015, Geneva, Switzerland; 15-18 April 2015
Save the date for the IMPAKT 2015 breast cancer conference: 7-9 May 2015
2015 ESMO World Congress on Gastrointestinal Cancer: 1-4 July 2015, Barcelona, Spain
Join us for this new course for medical oncologists: 28-30 August 2015, Oxford, UK
Save the date for the European Cancer Congess 2015: Vienna, Austria, 25-29 September 2015
Save the date for the ESMO Summit Americas. 6-8 November 2015, Miami, Florida
Join us in Barcelona, Spain. 12-15 November 2015
Join us in Lausanne, Switzerland: 20-21 November 2015
The first ESMO Asia congress will take place in Singapore, 18-21 December 2015
Mark you diaries now for ESMO 2016 in Copenhagen, Denmark. 7-11 October 2016
Save the date for ESMO 2017: 8-12 September 2017 in Madrid, Spain
Educational events on specific topics or cancer types and aim to provide a learning experience and training for young oncologists
View the complete list of ESMO oncology conferences including partnership, labelled and supported meetings.
Attending ELCC 2015 or IMPAKT 2015? Both programmes have been added to our Events App. Find out more about the app here!
Access information and reports from past ESMO events
Addressing the daily needs of ESMO young oncologists
Invest in your future and the future of cancer care. Learn more about our Oncology Fellowship Programme.
The latest oncology jobs can be found here, including information on how to post a job.
ESMO Full, Junior, Honorary and Emeritus members: we are now accepting nominations for the 2015 ESMO Awards
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology is now available in Serbian
ESMO fosters the advancement of cancer research by supporting clinical trials workshops to inspire young oncologists from different disciplines across the globe to become the next generation of active researchers.
ESMO members: are you planning on taking the ESMO examination this year? The late registration deadline is 22 July 2015
If you’ve already sat the ESMO exam, then take a look at our CME opportunities.
Discover the results of the ESMO Survey on the challenges faced by female oncologists
An ESMO pre-selected listing of the most recent EU research funding opportunities
Relevant information and tools to guide you through various EU grant application procedures
A selection of funding organisations to assist you in your projects
What`s available in terms of clinical research training and educational events
Clear, relevant information on EU clinical trials and data protection legislation
Useful links to partners and tools for your research projects
General European grant scheme information highlighting the main objectives, available funding and target audiences
Our cervical cancer, endometrial cancer and ovarian cancer patient guides are now available in Italian
Video interviews and articles designed to help patients, policy makers and other non-medical professionals better understand the principles of personalised cancer medicine
Now available in Greek, our Guide for Patients with Advanced Cancer is designed for patients, their family members and oncologists.
The ESMO Designated Centres of Integrated Oncology and Palliative Care accreditation programme recognises cancer centres which provide comprehensive services in supportive and palliative care as part of their routine care.
The ESMO Patient Track encourages communication between patients, families, oncologists and healthcare professionals.
Medical oncology is included among the medical specialities covered by the European Commission Directive 2005/36/EC.
ESMO’s political initiatives aim to promote the profession of medical oncology and keep cancer policy high on the European healthcare agenda.
ESMO position statements and recommendations can be downloaded here.
Rare Cancers Europe is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda.
The objective of this ESMO-led study is to provide health authorities with data on the availability of licensed anti-neoplastic medicines
ESMO has endorsed the 'Prague Charter: Relieving suffering' set up by the European Association for Palliative Care (EAPC) & other organisations
ESMO seeks to eradicate cancer at its earliest stages through effective cancer prevention awareness and advocacy campaigns.
Information about the EFPIA Disclosure Code which comes into effect 1 January 2015